End Cash: The amount of cash held by the company for the given period.
Biodexa Pharmaceuticals PLC Unsponsored ADR (BDRX) had End Cash of $11.25M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$16.41M |
|
$1.23M |
|
$8.68M |
|
$23.97M |
|
$8.08M |
|
-- |
|
$0.85M |
|
$8.93M |
|
$15.04M |
|
$7.60M |
|
$15.04M |
|
-- |
|
| Cash Flow Statement Financials | |
$-7.37M |
|
$-0.77M |
|
$17.20M |
|
$2.20M |
|
|
End Cash |
$11.25M |
$9.05M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|